Literature DB >> 8433728

Diagnostic value of blood sampling in fetuses with growth retardation.

G Pardi1, I Cetin, A M Marconi, A Lanfranchi, P Bozzetti, E Ferrazzi, M Buscaglia, F C Battaglia.   

Abstract

BACKGROUND: Fetuses with intrauterine growth retardation are delivered if they have evidence of distress, as manifested by abnormalities in the fetal heart rate and umbilical-artery blood flow. We studied whether umbilical-blood sampling might provide further information useful for management.
METHODS: We measured hemoglobin and lactate concentrations, oxygen content, pH, blood gas levels, and base deficit in umbilical-vein blood and correlated these measurements with the heart rate and umbilical-artery wave forms recorded by Doppler velocimetry in 56 fetuses with growth retardation. Twenty-one fetuses had normal heart rates and normal results of velocimetry, 24 had normal heart rates and abnormal results of velocimetry (indicative of decreased diastolic flow), and 11 had abnormal heart rates and abnormal results of velocimetry.
RESULTS: None of the 21 fetuses with normal heart rates and velocimetry had hypoxia or acidemia. Of the 24 fetuses with normal heart rates and abnormal velocimetry, 4 (17 percent) had moderate lactic acidosis, 1 (4 percent) had a low pH value, and 3 (12 percent) had hypoxia. Of the 11 fetuses with abnormal heart rates and velocimetry, 7 (64 percent) had lactic acidosis, low blood oxygen content, and low pH values. The absence of end-diastolic flow increased the risk of hypoxia and acidemia. The proportion of fetuses with elevated hemoglobin concentrations was similar among the three groups.
CONCLUSIONS: Assessment of fetal oxygenation and acid-base balance is not indicated in fetuses with growth retardation if their heart rates and the results of velocimetry are normal. If the results of velocimetry are abnormal, fetal-blood sampling can distinguish fetuses that have growth retardation alone from those that also have hypoxia and acidosis, and thus may aid in determining the optimal time of delivery.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8433728     DOI: 10.1056/NEJM199303113281004

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  50 in total

1.  Global protein synthesis in human trophoblast is resistant to inhibition by hypoxia.

Authors:  S F Williams; E Fik; S Zamudio; N P Illsley
Journal:  Placenta       Date:  2011-11-10       Impact factor: 3.481

Review 2.  Placental angiogenesis in sheep models of compromised pregnancy.

Authors:  Lawrence P Reynolds; Pawel P Borowicz; Kimberly A Vonnahme; Mary Lynn Johnson; Anna T Grazul-Bilska; Dale A Redmer; Joel S Caton
Journal:  J Physiol       Date:  2005-03-10       Impact factor: 5.182

Review 3.  ASAS-SSR Triennnial Reproduction Symposium: Looking Back and Moving Forward-How Reproductive Physiology has Evolved: Fetal origins of impaired muscle growth and metabolic dysfunction: Lessons from the heat-stressed pregnant ewe.

Authors:  Dustin T Yates; Jessica L Petersen; Ty B Schmidt; Caitlin N Cadaret; Taylor L Barnes; Robert J Posont; Kristin A Beede
Journal:  J Anim Sci       Date:  2018-06-29       Impact factor: 3.159

4.  Intrauterine growth restriction improves cerebral O2 utilization during hypercapnic hypoxia in newborn piglets.

Authors:  Reinhard Bauer; Bernd Walter; Ulrich Brandl
Journal:  J Physiol       Date:  2007-08-23       Impact factor: 5.182

5.  Where the O2 goes to: preservation of human fetal oxygen delivery and consumption at high altitude.

Authors:  Lucrecia Postigo; Gladys Heredia; Nicholas P Illsley; Tatiana Torricos; Caitlin Dolan; Lourdes Echalar; Wilma Tellez; Ivan Maldonado; Michael Brimacombe; Elfride Balanza; Enrique Vargas; Stacy Zamudio
Journal:  J Physiol       Date:  2008-12-15       Impact factor: 5.182

6.  Liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP-1 phosphorylation in fetal growth restriction.

Authors:  Majida Abu Shehab; Ian Damerill; Tong Shen; Fredrick J Rosario; Mark Nijland; Peter W Nathanielsz; Amrita Kamat; Thomas Jansson; Madhulika B Gupta
Journal:  Endocrinology       Date:  2014-01-17       Impact factor: 4.736

7.  Circulating levels of growth hormone, insulin-like growth factor-I and prolactin in normal, growth retarded and anencephalic human fetuses.

Authors:  M Arosio; D Cortelazzi; L Persani; E Palmieri; G Casati; A M Baggiani; G Gambino; P Beck-Peccoz
Journal:  J Endocrinol Invest       Date:  1995-05       Impact factor: 4.256

8.  Chronic exposure to elevated norepinephrine suppresses insulin secretion in fetal sheep with placental insufficiency and intrauterine growth restriction.

Authors:  Rafael A Leos; Miranda J Anderson; Xiaochuan Chen; Juliana Pugmire; K Arbor Anderson; Sean W Limesand
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-01-19       Impact factor: 4.310

9.  Severe intrauterine growth restriction pregnancies have increased placental endoglin levels: hypoxic regulation via transforming growth factor-beta 3.

Authors:  Yoav Yinon; Ori Nevo; Jing Xu; Ariel Many; Alessandro Rolfo; Tullia Todros; Martin Post; Isabella Caniggia
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

10.  Hypoxia induces dilated cardiomyopathy in the chick embryo: mechanism, intervention, and long-term consequences.

Authors:  Andrei Tintu; Ellen Rouwet; Stefan Verlohren; Joep Brinkmann; Shakil Ahmad; Fatima Crispi; Marc van Bilsen; Peter Carmeliet; Anne Cathrine Staff; Marc Tjwa; Irene Cetin; Eduard Gratacos; Edgar Hernandez-Andrade; Leo Hofstra; Michael Jacobs; Wouter H Lamers; Ingo Morano; Erdal Safak; Asif Ahmed; Ferdinand le Noble
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.